IDEAYA Biosciences, Inc. (IDYA) has 20 알려진 내부자 및 기관 보유자 기록. 최대 보유자는 Hata Yujiro S 600,000 주 보유. 기타 주요 보유자에는 BVF PARTNERS L P/IL 및 WHITE MICHAEL ANTHONY.
지난 12개월간 내부자는 19 건의 거래를 수행 IDYA 주식 — 18 건 매수 (평가액 $52.62M) 및 0 건 매도 (평가액 RSU 보상). 내부자 매수가 매도를 초과하여 회사 전망에 대한 자신감의 신호일 수 있습니다.
IDYA 내부자 보유 현황
최대 보유자
Hata Yujiro S
600,000 주
내부자 주요 보유자
| # |
이름 |
직책 |
보유 주식수 |
최종 신고일 |
상대적 규모 |
| 1 |
Hata Yujiro S |
President and CEO |
600,000 |
2026-02-02 |
|
| 2 |
Bvf Partners L P/il |
Officer |
233,150 |
2021-02-04 |
|
| 3 |
White Michael Anthony |
Chief Scientific Officer |
190,000 |
2026-02-02 |
|
| 4 |
Beaupre Darrin |
Chief Medical Officer |
175,000 |
2026-02-02 |
|
| 5 |
Bleharski Joshua |
Chief Financial Officer |
170,000 |
2026-02-02 |
|
| 6 |
Dorman Stuart |
Chief Commercial Officer |
155,000 |
2026-02-02 |
|
| 7 |
5am Ventures Iv, L.p. |
10 Percent Owner |
91,142 |
2020-11-13 |
|
| 8 |
Hambleton Julie |
SVP, Chief Medical Officer |
62,500 |
2020-02-25 |
|
| 9 |
Stein Jeffrey |
Director |
54,281 |
2026-03-02 |
|
| 10 |
Lackner Mark |
SVP, Head of Biology |
45,000 |
2021-02-26 |
|
| 11 |
Ruiz Briseno Andres |
See Remarks |
25,213 |
2026-02-02 |
|
| 12 |
Dillon Michael P. |
SVP, Chief Scientific Officer |
23,437 |
2021-10-07 |
|
| 13 |
Hampton Malcolm Garret |
Director |
20,000 |
2025-06-26 |
|
| 14 |
Morrison Scott W |
Director |
20,000 |
2025-06-26 |
|
| 15 |
Mackey Catherine J |
Director |
20,000 |
2025-06-26 |
|
| 16 |
Rosen Terry J |
Director |
20,000 |
2025-06-26 |
|
| 17 |
Yarno Wendy L |
Director |
20,000 |
2025-06-26 |
|
| 18 |
Shannon Timothy M |
Director |
16,200 |
2023-06-09 |
|
| 19 |
Kelley Susan L. |
Director |
16,200 |
2024-05-31 |
|
| 20 |
Diekman John D |
Director |
11,000 |
2019-12-19 |
|
최근 거래 (최근 12개월)
| 날짜 |
이름 |
직책 |
유형 |
주식수 |
주가 |
금액 |
| 2026-03-02 |
Stein Jeffrey |
Director |
정보 매수 |
50,000 |
$32.96 |
$1.65M |
| 2026-01-30 |
Bleharski Joshua |
Chief Financial Officer |
RSU 부여 |
170,000 |
$32.19 |
$5.47M |
| 2026-01-30 |
Dorman Stuart |
Chief Commercial Officer |
RSU 부여 |
155,000 |
$32.19 |
$4.99M |
| 2026-01-30 |
Ruiz Briseno Andres |
See Remarks |
RSU 부여 |
80,000 |
$32.19 |
$2.58M |
| 2025-11-28 |
Ruiz Briseno Andres |
See Remarks |
RSU 부여 |
1,253 |
$16.91 |
$21.18K |
| 2024-11-29 |
Ruiz Briseno Andres |
See Remarks |
RSU 부여 |
682 |
$23.26 |
$15.86K |
| 2026-01-30 |
White Michael Anthony |
Chief Scientific Officer |
RSU 부여 |
190,000 |
$32.19 |
$6.12M |
| 2026-01-30 |
Snyder Douglas B. |
SVP, General Counsel |
RSU 부여 |
130,000 |
$32.19 |
$4.18M |
| 2025-11-28 |
Snyder Douglas B. |
SVP, General Counsel |
RSU 부여 |
1,041 |
$16.91 |
$17.6K |
| 2025-05-30 |
Snyder Douglas B. |
SVP, General Counsel |
RSU 부여 |
1,039 |
$16.91 |
$17.57K |
| 2026-01-30 |
Hata Yujiro S |
President and CEO |
RSU 부여 |
600,000 |
$32.19 |
$19.31M |
| 2026-01-30 |
Beaupre Darrin |
Chief Medical Officer |
RSU 부여 |
175,000 |
$32.19 |
$5.63M |
| 2025-06-27 |
Bleharski Joshua |
Chief Financial Officer |
알 수 없음 |
250,000 |
$20.05 |
$5.01M |
| 2025-06-24 |
Hampton Malcolm Garret |
Director |
RSU 부여 |
20,000 |
$21.78 |
$435.6K |
| 2025-06-24 |
Morrison Scott W |
Director |
RSU 부여 |
20,000 |
$21.78 |
$435.6K |
| 2025-06-24 |
Mackey Catherine J |
Director |
RSU 부여 |
20,000 |
$21.78 |
$435.6K |
| 2025-06-24 |
Stein Jeffrey |
Director |
RSU 부여 |
20,000 |
$21.78 |
$435.6K |
| 2025-06-24 |
Rosen Terry J |
Director |
RSU 부여 |
20,000 |
$21.78 |
$435.6K |
| 2025-06-24 |
Yarno Wendy L |
Director |
RSU 부여 |
20,000 |
$21.78 |
$435.6K |
